Literature DB >> 15246321

Programmed cell death in trypanosomatids: a way to maximize their biological fitness?

Paul A Nguewa1, Miguel A Fuertes, Basilio Valladares, Carlos Alonso, José M Pérez.   

Abstract

Programmed cell death (PCD) is a biochemical process that plays an essential role in the development of multicellular organisms. However, accumulating evidence indicates that PCD is also present in single-celled eukaryotes. Thus, trypanosomatids might be endowed with a PCD mechanism that is derived from ancestral death machinery. PCD in trypanosomatids could be a process without a defined function, inherited through eukaryotic cell evolution, which might be triggered in response to diverse stimuli and stress conditions. However, recent observations suggest that PCD might be used by trypanosomatids to maximize their biological fitness. Therefore, PCD could represent a potential pharmacological target for protozoan control.

Entities:  

Mesh:

Year:  2004        PMID: 15246321     DOI: 10.1016/j.pt.2004.05.006

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  22 in total

Review 1.  Phospholipid and sphingolipid metabolism in Leishmania.

Authors:  Kai Zhang; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2009-12-23       Impact factor: 1.759

Review 2.  Imaging and therapeutic applications of zinc(ii)-dipicolylamine molecular probes for anionic biomembranes.

Authors:  Douglas R Rice; Kasey J Clear; Bradley D Smith
Journal:  Chem Commun (Camb)       Date:  2016-07-07       Impact factor: 6.222

3.  Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii.

Authors:  Carmen M Martín-Navarro; Atteneri López-Arencibia; Ines Sifaoui; María Reyes-Batlle; Basilio Valladares; Enrique Martínez-Carretero; José E Piñero; Sutherland K Maciver; Jacob Lorenzo-Morales
Journal:  Antimicrob Agents Chemother       Date:  2015-03-02       Impact factor: 5.191

4.  Antiparasitic lethality of sulfonamidebenzamides in kinetoplastids.

Authors:  Amber Hackler; Stephen L Patrick; Elizabeth W Kahney; Daniel P Flaherty; Elizabeth R Sharlow; James C Morris; Jennifer E Golden
Journal:  Bioorg Med Chem Lett       Date:  2017-01-16       Impact factor: 2.823

5.  Design and evaluation of Trypanosoma brucei metacaspase inhibitors.

Authors:  Maya Berg; Pieter Van der Veken; Jurgen Joossens; Venkatraj Muthusamy; Matthias Breugelmans; Catherine X Moss; Jana Rudolf; Paul Cos; Graham H Coombs; Louis Maes; Achiel Haemers; Jeremy C Mottram; Koen Augustyns
Journal:  Bioorg Med Chem Lett       Date:  2010-01-25       Impact factor: 2.823

6.  Characterization of metacaspases with trypsin-like activity and their putative role in programmed cell death in the protozoan parasite Leishmania.

Authors:  Nancy Lee; Sreenivas Gannavaram; Angamuthu Selvapandiyan; Alain Debrabant
Journal:  Eukaryot Cell       Date:  2007-08-22

7.  Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani.

Authors:  Sayan Chowdhury; Tulika Mukherjee; Somenath Roy Chowdhury; Souvik Sengupta; Sibabrata Mukhopadhyay; Parasuraman Jaisankar; Hemanta K Majumder
Journal:  Antimicrob Agents Chemother       Date:  2014-01-27       Impact factor: 5.191

Review 8.  Cell death in parasitic protozoa: regulated or incidental?

Authors:  William R Proto; Graham H Coombs; Jeremy C Mottram
Journal:  Nat Rev Microbiol       Date:  2012-12-03       Impact factor: 60.633

Review 9.  Apoptosis and apoptotic mimicry in Leishmania: an evolutionary perspective.

Authors:  Charbel N El-Hani; Valéria M Borges; João L M Wanderley; Marcello A Barcinski
Journal:  Front Cell Infect Microbiol       Date:  2012-07-12       Impact factor: 5.293

10.  Differential trypanocidal activity of novel macrolide antibiotics; correlation to genetic lineage.

Authors:  Carolina Aquilino; Maria Luisa Gonzalez Rubio; Elena Maria Seco; Leticia Escudero; Laura Corvo; Manuel Soto; Manuel Fresno; Francisco Malpartida; Pedro Bonay
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.